Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor Ligands

Medical treatment for acromegaly commonly involves receiving intramuscular or deep subcutaneous injections of somatostatin receptor ligands (SRLs) in most patients. In addition to side effects of treatment, acromegaly patients often still experience disease symptoms even when therapy is successful i...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Endocrinol (Lausanne)
Главные авторы: Fleseriu, Maria, Molitch, Mark, Dreval, Alexander, Biermasz, Nienke R., Gordon, Murray B., Crosby, Ross D., Ludlam, William H., Haviv, Asi, Gilgun-Sherki, Yossi, Mathias, Susan D.
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2021
Предметы:
Endocrinology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8006928/
https://ncbi.nlm.nih.gov/pubmed/33790860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.627711
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы